Efficacy and Safety of Insulin RinGlar ® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus Interventions: Drug: Lantus Solostar, 100 Units/mL Subcutaneous Solution; Drug: Insulin RinGlar, 100 Units/mL Subcutaneous Solution Sponsor: Geropharm Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 1 | Endocrinology | Insulin | Lantus | Research